Molecular Diagnostics of Bacterial Infections and Antibiotic Resistance in Blood Samples and Rectal Swabs Using Advanced NGS Sequencing Methods

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 28, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Resistance Bacterial
Interventions
DIAGNOSTIC_TEST

NGS Analysis

An analytical pipeline with NGS technology developed in the GENRES study will be used for the identification of infecting microorganisms and the drug resistance they carry. For this purpose, a sequencing method will be identified and adopted that can obtain gene sequences of approximately 75 bp in length and on the Illumina MiSeq platform. Furthermore, IT software and bioinformatics analyzes with specific quality control parameters (pre- and post-alignment of reads) will be identified and adopted in order to develop an IVD system that includes a complete package of sequencing kits and software.

Trial Locations (1)

37024

RECRUITING

IRCCS Sacro Cuore Don Calabria hospital, Negrar

All Listed Sponsors
lead

IRCCS Sacro Cuore Don Calabria di Negrar

OTHER